TRENTON, N.J., Dec. 08, 2016 -- In response to the proposed surgical declawing ban now before the New Jersey Assembly (A3899) and the Senate (S2410), the New Jersey Veterinary Medical Association (NJVMA) launched a public campaign at LoveYourCats.org opposing the increased euthanasia that would certainly result from a surgical declawing ban.
Surgical declawing with advanced pain control methods is recommended by doctors as a last resort, as an alternative to euthanasia or abandonment.
“We want to see cats in loving, caring households,” says Dr. Michael Yurkus of the NJVMA. “We know that 72% of all cats sent to shelters will be euthanized, and this is a 100% preventable tragedy. As the leading advocates for saving the lives of unwanted or discarded animals, we’re laying out the vital facts and calling on concerned citizens to oppose this legislation at LoveYourCats.org.”
While veterinarians have reduced declawing through better education regarding the alternatives, the NJVMA is especially concerned for cats living with people taking immunity suppressing medication or blood thinners, or people with blood disorders, where an animal scratch would pose a health risk. Also of concern are the cats living with the elderly in facilities that require cats to be declawed.
About the New Jersey Veterinary Medical Association (NJVMA)
Founded in 1884 as a professional association representing the state’s 1,600 licensed veterinarians, the NJVMA is dedicated to advancing the veterinary profession in New Jersey, protecting the health of animals and extending progressive leadership in the research, care, treatment, and welfare of animals. The NJVMA encourages high ethical standards and competence in the treatment of animals and promotes excellence in the professional training and continuing education of doctors of veterinary medicine. The association is a nexus point for all the issues, factors, and organizations that will have an impact on New Jersey’s veterinarians. For more information, go to www.njvma.org
Contact Karen Geisel at (518) 421-3435


Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
Seatrium Reaches $475 Million Settlement With Maersk Over Offshore Wind Vessel Project
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand
Italy Fines Apple €98.6 Million Over App Store Dominance
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing 



